JAMA Pediatrics: Published on November 2022
A Systematic Review and Meta-analysis
TAKE-HOME MESSAGE
Are shorter courses of
antibiotics as good as longer courses?
This systematic review and meta-analysis assessed whether
shorter courses of antibiotics are noninferior to longer courses of antibiotics
for nonsevere community-acquired pneumonia (CAP) in children.
The studies included compared 3-day courses with 5- to 10-day
courses and 5-day courses with 7- to 10-day courses; the outcomes evaluated
included treatment failure, post-treatment fever, hospitalization, antibiotic
change, and death.
In this systematic review and meta-analysis of 11,143
children with nonsevere community-acquired pneumonia, more than 95% of the
participants were aged 2 to 59 months, and treatment failure occurred in 12.8%
vs 12.6% of those randomized to a shorter vs a longer course of antibiotics.
The results showed that a 3-day course was noninferior to a
5-day course and that a 5-day course was noninferior to a 10-day course, with
shorter courses being associated with lower rates of gastroenteritis and
caregiver absenteeism.
In children with nonsevere CAP, providers should consider prescribing a shorter course (3–5 days) of antibiotics. Short courses are not only noninferior to longer courses but reduce the incidence of adverse drug effects and treatment costs and likely increase treatment adherence.
Importance: Short-course antibiotic therapy could enhance adherence and
reduce adverse drug effects and costs. However, based on sparse evidence, most
guidelines recommend a longer course of antibiotics for nonsevere childhood
community-acquired pneumonia (CAP).
Objective: To determine whether a shorter course of antibiotics was
noninferior to a longer course for childhood nonsevere CAP.
Data sources: MEDLINE, Embase, Web of Science, the Cochrane Library, and 3
Chinese databases from inception to March 31, 2022, as well as clinical trial
registries and Google.com.
Study selection: Randomized clinical trials comparing a shorter- vs
longer-course therapy using the same oral antibiotic for children with
nonsevere CAP were included.
Data extraction and synthesis: Random-effects models were used to
pool the data, which were analyzed from April 15, 2022, to May 15, 2022.
Grading of Recommendations Assessment, Development and Evaluation (GRADE) was
used to rate the quality of the evidence.
Main outcomes and measures: Treatment failure, defined by
persistence of pneumonia or the new appearance of any general danger signs of
CAP (eg, lethargy, unconsciousness, seizures, or inability to drink), elevated
temperature (>38 °C) after completion of treatment, change of antibiotic,
hospitalization, death, missing more than 3 study drug doses, loss to
follow-up, or withdrawal of informed consent.
Results: Nine randomized clinical trials including 11 143 participants
were included in this meta-analysis. A total of 98% of the participants were
aged 2 to 59 months, and 58% were male. Eight studies with 10 662 patients
reported treatment failure. Treatment failure occurred in 12.8% vs 12.6% of
participants randomized to shorter vs a longer course of antibiotics.
High-quality evidence showed that a shorter course of oral antibiotic was
noninferior to a longer course with respect to treatment failure for children
with nonsevere CAP. A 3-day course of antibiotic treatment was noninferior to a
5-day course for the outcome of treatment failure, and a 5-day course was
noninferior to a 10-day course. A shorter course of antibiotics was associated
with fewer reports of gastroenteritis and lower caregiver absenteeism.
Conclusions and relevance: Results of this meta-analysis suggest
that a shorter course of antibiotics was noninferior to a longer course in
children aged 2 to 59 months with nonsevere CAP. Clinicians should consider
prescribing a shorter course of antibiotics for the management of pediatric
nonsevere CAP.
Comments
You must login to write comment